TruAlt Bioenergy Shares Set to Debut with Anticipated 18% Premium
TruAlt Bioenergy Ltd. is set to list on BSE and NSE. The Rs 839-crore IPO was oversubscribed 65.01 times. Grey market trends suggest a potential 18% premium on listing, with an estimated listing price of Rs 586.00 compared to the IPO price of Rs 496.00. The IPO included a fresh issue of Rs 750.00 crore and an offer-for-sale of Rs 89.28 crore. Funds will be used for capital expenditure, working capital, and general corporate purposes.

*this image is generated using AI for illustrative purposes only.
TruAlt Bioenergy Ltd. is poised for a strong market debut as its shares are scheduled to list on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE) today. The company's Initial Public Offering (IPO) has generated significant buzz in the investment community, with grey market trends suggesting a potential 18% premium on listing.
IPO Performance
The Rs 839-crore IPO of TruAlt Bioenergy witnessed overwhelming investor interest, resulting in an impressive oversubscription of 65.01 times. The offer received bids for 88.86 crore shares against the 1.24 crore shares available, highlighting the strong demand from investors.
Grey Market Premium
The grey market, often considered an indicator of listing day performance, is showing a premium of Rs 90 for TruAlt Bioenergy shares. This suggests an estimated listing price of Rs 586.00, compared to the upper price band of Rs 496.00 set during the IPO. If this holds true, investors could potentially see gains of approximately 18.15% on the first day of trading.
IPO Structure and Fund Allocation
The IPO comprised two components:
- A fresh issue of shares worth Rs 750.00 crore
- An offer-for-sale amounting to Rs 89.28 crore
The company has outlined its plans for utilizing the proceeds from the fresh issue:
- Rs 150.00 crore allocated for capital expenditure
- Rs 425.00 crore earmarked for working capital requirements
- The remaining funds to be used for general corporate purposes
Investor Participation
The success of the IPO was largely driven by strong participation from non-institutional buyers, indicating confidence in the company's prospects among a diverse range of investors.
As TruAlt Bioenergy prepares for its market debut, all eyes will be on its performance in the early hours of trading. The substantial oversubscription and positive grey market premium suggest a favorable reception from the investment community, setting the stage for what could be a noteworthy listing day for the company.